Research at Kaiser Permanente points to bupropion (Wellbutrin) as first choice for overweight and obese patients with depression.
UW and GHRI researchers have come up with innovative maps that illustrate the link between wealth accumulation and diet quality.
Dr. David Arterburn talks about his studies with Kaiser and other systems to help a rapidly increasing population with severe obesity.
Study leader Dr. David Arterburn will use PCORnet, new national clinical research network, to speed results.
Study leader Dr. David Arterburn will use PCORnet, new national clinical research network, to speed results.
Group Health Physician and GHRI Associate Investigator Beverly Green, MD, MPH, weighs in on obesity advice from a group sponsored by Coca-Cola.
Dr. David Arterburn has new studies on the costs, care variation, and effect on life expectancy of bariatric surgery. The results could guide obesity care.
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.